Breast cancer prognosis determined by gene expression profiling: a quantitative reverse transcriptase polymerase...

Area of Science:

• Oncology
• Molecular Biology
• Genomics

Background:

• Gene expression profiling is crucial for understanding breast cancer.
• Previous studies identified a 70-gene profile for predicting prognosis.
• Validating this profile with alternative methods is essential for clinical application.

Purpose of the Study:

• To validate a previously described 70-gene expression profile in early-stage breast cancer.
• To reproduce microarray-based gene expression results using quantitative reverse-transcriptase polymerase chain reaction (qRT-PCR).
• To assess the prognostic value of the gene profile in relation to patient survival and clinical data.

Main Methods:

• Tumor RNA was isolated from frozen breast cancer samples of 96 patients (Stage I-II).
• Quantitative reverse-transcriptase polymerase chain reaction (qRT-PCR) was used for gene amplification.
• Results were correlated with clinical data, including lymph node status, tumor grade, size, and hormone receptor status.

Main Results:

• The 70-gene profile divided patients into poor and good prognosis groups.
• Significant differences in differentiation grade, size, and hormone receptors were observed between groups.
• The gene profile was significantly associated with relapse-free and overall survival.
• Multivariate analysis identified lymph node status and the gene profile as significant predictors of overall survival.

Conclusions:

• Quantitative reverse-transcriptase polymerase chain reaction (qRT-PCR) effectively reproduced the prognostic gene profile results obtained via microarrays.
• The validated gene profile holds significant prognostic value for women with early-stage breast cancer.
• This method provides a reliable tool for assessing survival outcomes in early-stage breast cancer patients.